147 related articles for article (PubMed ID: 6122292)
1. Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects.
Dahl SG
Ther Drug Monit; 1982; 4(1):33-40. PubMed ID: 6122292
[TBL] [Abstract][Full Text] [Related]
2. Plasma level monitoring of antipsychotic drugs. Clinical utility.
Dahl SG
Clin Pharmacokinet; 1986; 11(1):36-61. PubMed ID: 2868820
[TBL] [Abstract][Full Text] [Related]
3. Phenothiazine drug metabolites: dopamine D2 receptor, alpha 1- and alpha 2-adrenoceptor binding.
Hals PA; Hall H; Dahl SG
Eur J Pharmacol; 1986 Jun; 125(3):373-81. PubMed ID: 2874041
[TBL] [Abstract][Full Text] [Related]
4. Blood levels of neuroleptics: state of the art.
Simpson GM; Yadalam K
J Clin Psychiatry; 1985 May; 46(5 Pt 2):22-8. PubMed ID: 2859277
[TBL] [Abstract][Full Text] [Related]
5. [Relations between the levels of neuroleptics and the doses, the therapeutic effects and the side effects].
Davy JP; Moulin M; Andersson JC; Halbecq JJ; Morel P; Poilpre E
Encephale; 1978; 4(4):293-321. PubMed ID: 33791
[TBL] [Abstract][Full Text] [Related]
6. Drug distribution between blood and brain as a determinant of antipsychotic drug effects.
Tsuneizumi T; Babb SM; Cohen BM
Biol Psychiatry; 1992 Nov; 32(9):817-24. PubMed ID: 1360262
[TBL] [Abstract][Full Text] [Related]
7. Phototoxic properties of neuroleptic drugs.
Eberlein-König B; Bindl A; Przybilla B
Dermatology; 1997; 194(2):131-5. PubMed ID: 9094460
[TBL] [Abstract][Full Text] [Related]
8. Binding affinity of levomepromazine and two of its major metabolites of central dopamine and alpha-adrenergic receptors in the rat.
Dahl SG; Hall H
Psychopharmacology (Berl); 1981; 74(2):101-4. PubMed ID: 6115442
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites.
Hals PA; Hall H; Dahl SG
Life Sci; 1988; 43(5):405-12. PubMed ID: 2899826
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic, antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine, and their metabolites.
Cohen BM; Herschel M; Aoba A
Psychiatry Res; 1979 Oct; 1(2):199-208. PubMed ID: 45131
[TBL] [Abstract][Full Text] [Related]
11. Blood levels of neuroleptic drugs in nonresponding chronic schizophrenic patients.
Smith RC; Crayton J; Dekirmenjian H; Klass D; Davis JM
Arch Gen Psychiatry; 1979 May; 36(5):579-84. PubMed ID: 35115
[TBL] [Abstract][Full Text] [Related]
12. Anti-apomorphine effects of phenothiazine drug metabolites.
Morel E; Lloyd KG; Dahl SG
Psychopharmacology (Berl); 1987; 92(1):68-72. PubMed ID: 2885882
[TBL] [Abstract][Full Text] [Related]
13. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
14. Chlorpromazine, methotrimeprazine, and metabolites. Structural changes accompanying the loss of neuroleptic potency by ring sulfoxidation.
Dahl SG; Hjorth M; Hough E
Mol Pharmacol; 1982 Mar; 21(2):409-14. PubMed ID: 6124878
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution.
Kornhuber J; Wiltfang J; Riederer P; Bleich S
Eur Arch Psychiatry Clin Neurosci; 2006 Aug; 256(5):274-80. PubMed ID: 16788768
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic plasma levels.
Van Putten T; Marder SR; Wirshing WC; Aravagiri M; Chabert N
Schizophr Bull; 1991; 17(2):197-216. PubMed ID: 1679251
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of neuroleptic agents on the pituitary-gonadal axis in men.
Brown WA; Laughren TP; Williams B
Arch Gen Psychiatry; 1981 Nov; 38(11):1270-2. PubMed ID: 6118109
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
[TBL] [Abstract][Full Text] [Related]
19. Plasma and erythrocyte levels of methotrimeprazine and two of its nonpolar metabolites in psychiatric patients.
Dahl SG; Bratlid T; Lingjaerde O
Ther Drug Monit; 1982; 4(1):81-7. PubMed ID: 7071908
[TBL] [Abstract][Full Text] [Related]
20. Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics.
Young AS; Faraone SV; Brown WA
J Clin Psychopharmacol; 1989 Oct; 9(5):361-3. PubMed ID: 2571620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
